Logo image of MIR

MIRION TECHNOLOGIES INC (MIR) Stock Fundamental Analysis

NYSE:MIR - New York Stock Exchange, Inc. - US60471A1016 - Common Stock

16.55  +0.29 (+1.78%)

After market: 16.55 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MIR. MIR was compared to 126 industry peers in the Electronic Equipment, Instruments & Components industry. MIR has only an average score on both its financial health and profitability. MIR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MIR had positive earnings in the past year.
MIR had a positive operating cash flow in the past year.
MIR had negative earnings in each of the past 5 years.
Each year in the past 5 years MIR had a positive operating cash flow.
MIR Yearly Net Income VS EBIT VS OCF VS FCFMIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -100M -200M

1.2 Ratios

MIR has a Return On Assets of -2.50%. This is comparable to the rest of the industry: MIR outperforms 43.80% of its industry peers.
Looking at the Return On Equity, with a value of -4.37%, MIR is in line with its industry, outperforming 45.45% of the companies in the same industry.
MIR has a Return On Invested Capital (0.40%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.5%
ROE -4.37%
ROIC 0.4%
ROA(3y)-7.97%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIR Yearly ROA, ROE, ROICMIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 10 -10

1.3 Margins

MIR has a Operating Margin (1.45%) which is comparable to the rest of the industry.
Looking at the Gross Margin, with a value of 46.11%, MIR belongs to the top of the industry, outperforming 80.17% of the companies in the same industry.
In the last couple of years the Gross Margin of MIR has grown nicely.
Industry RankSector Rank
OM 1.45%
PM (TTM) N/A
GM 46.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.6%
GM growth 5YN/A
MIR Yearly Profit, Operating, Gross MarginsMIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MIR is destroying value.
Compared to 1 year ago, MIR has more shares outstanding
MIR has a better debt/assets ratio than last year.
MIR Yearly Shares OutstandingMIR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 50M 100M 150M 200M
MIR Yearly Total Debt VS Total AssetsMIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

MIR has an Altman-Z score of 2.17. This is not the best score and indicates that MIR is in the grey zone with still only limited risk for bankruptcy at the moment.
MIR has a worse Altman-Z score (2.17) than 66.94% of its industry peers.
MIR has a debt to FCF ratio of 12.17. This is a negative value and a sign of low solvency as MIR would need 12.17 years to pay back of all of its debts.
With a Debt to FCF ratio value of 12.17, MIR perfoms like the industry average, outperforming 51.24% of the companies in the same industry.
MIR has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MIR (0.45) is worse than 69.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 12.17
Altman-Z 2.17
ROIC/WACC0.04
WACC10.38%
MIR Yearly LT Debt VS Equity VS FCFMIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.16 indicates that MIR has no problem at all paying its short term obligations.
MIR has a Current ratio of 2.16. This is comparable to the rest of the industry: MIR outperforms 43.80% of its industry peers.
MIR has a Quick Ratio of 1.55. This is a normal value and indicates that MIR is financially healthy and should not expect problems in meeting its short term obligations.
MIR has a Quick ratio (1.55) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.55
MIR Yearly Current Assets VS Current LiabilitesMIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

MIR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
Looking at the last year, MIR shows a small growth in Revenue. The Revenue has grown by 6.15% in the last year.
Measured over the past years, MIR shows a quite strong growth in Revenue. The Revenue has been growing by 18.76% on average per year.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)6.15%
Revenue growth 3Y18.76%
Revenue growth 5YN/A
Sales Q2Q%8.16%

3.2 Future

The Earnings Per Share is expected to grow by 25.98% on average over the next years. This is a very strong growth
Based on estimates for the next years, MIR will show a small growth in Revenue. The Revenue will grow by 6.94% on average per year.
EPS Next Y15.85%
EPS Next 2Y22.66%
EPS Next 3Y25.98%
EPS Next 5YN/A
Revenue Next Year7.87%
Revenue Next 2Y6.72%
Revenue Next 3Y6.94%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MIR Yearly Revenue VS EstimatesMIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
MIR Yearly EPS VS EstimatesMIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 42.44, the valuation of MIR can be described as expensive.
MIR's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.96. MIR is valued rather expensively when compared to this.
MIR is valuated quite expensively with a Price/Forward Earnings ratio of 32.35.
The rest of the industry has a similar Price/Forward Earnings ratio as MIR.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.11, MIR is valued a bit more expensive.
Industry RankSector Rank
PE 42.44
Fwd PE 32.35
MIR Price Earnings VS Forward Price EarningsMIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

MIR's Enterprise Value to EBITDA ratio is in line with the industry average.
MIR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 68.28
EV/EBITDA 25.71
MIR Per share dataMIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MIR does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as MIR's earnings are expected to grow with 25.98% in the coming years.
PEG (NY)2.68
PEG (5Y)N/A
EPS Next 2Y22.66%
EPS Next 3Y25.98%

0

5. Dividend

5.1 Amount

No dividends for MIR!.
Industry RankSector Rank
Dividend Yield N/A

MIRION TECHNOLOGIES INC

NYSE:MIR (1/17/2025, 8:14:53 PM)

After market: 16.55 0 (0%)

16.55

+0.29 (+1.78%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-29 2024-10-29/amc
Earnings (Next)02-11 2025-02-11/amc
Inst Owners88.45%
Inst Owner Change0%
Ins Owners0.61%
Ins Owner Change17.32%
Market Cap3.84B
Analysts84.44
Price Target19.58 (18.31%)
Short Float %2.26%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.01%
Min EPS beat(2)-11.99%
Max EPS beat(2)32.01%
EPS beat(4)2
Avg EPS beat(4)6.26%
Min EPS beat(4)-11.99%
Max EPS beat(4)32.01%
EPS beat(8)5
Avg EPS beat(8)9.12%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.09%
Min Revenue beat(2)-2.72%
Max Revenue beat(2)0.53%
Revenue beat(4)2
Avg Revenue beat(4)0.42%
Min Revenue beat(4)-2.72%
Max Revenue beat(4)4.22%
Revenue beat(8)6
Avg Revenue beat(8)2.28%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)23.87%
PT rev (3m)51.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.39%
EPS NY rev (1m)0.65%
EPS NY rev (3m)-0.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 42.44
Fwd PE 32.35
P/S 4.59
P/FCF 68.28
P/OCF 36.5
P/B 2.53
P/tB N/A
EV/EBITDA 25.71
EPS(TTM)0.39
EY2.36%
EPS(NY)0.51
Fwd EY3.09%
FCF(TTM)0.24
FCFY1.46%
OCF(TTM)0.45
OCFY2.74%
SpS3.6
BVpS6.54
TBVpS-1.64
PEG (NY)2.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.5%
ROE -4.37%
ROCE 0.5%
ROIC 0.4%
ROICexc 0.42%
ROICexgc 2.64%
OM 1.45%
PM (TTM) N/A
GM 46.11%
FCFM 6.73%
ROA(3y)-7.97%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.6%
GM growth 5YN/A
F-Score5
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 12.17
Debt/EBITDA 4.08
Cap/Depr 31.45%
Cap/Sales 5.85%
Interest Coverage 0.21
Cash Conversion 62.72%
Profit Quality N/A
Current Ratio 2.16
Quick Ratio 1.55
Altman-Z 2.17
F-Score5
WACC10.38%
ROIC/WACC0.04
Cap/Depr(3y)23.38%
Cap/Depr(5y)24.59%
Cap/Sales(3y)4.4%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y15.85%
EPS Next 2Y22.66%
EPS Next 3Y25.98%
EPS Next 5YN/A
Revenue 1Y (TTM)6.15%
Revenue growth 3Y18.76%
Revenue growth 5YN/A
Sales Q2Q%8.16%
Revenue Next Year7.87%
Revenue Next 2Y6.72%
Revenue Next 3Y6.94%
Revenue Next 5YN/A
EBIT growth 1Y142.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year900.94%
EBIT Next 3Y135.27%
EBIT Next 5YN/A
FCF growth 1Y1017.31%
FCF growth 3Y43.65%
FCF growth 5YN/A
OCF growth 1Y141.62%
OCF growth 3Y34.07%
OCF growth 5YN/A